Exploratory, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single Center, Web-Based Phase IV Pilot Methodology Trial To Evaluate The Efficacy And Safety Of Tolterodine ER In Subjects With Overactive Bladder.
Phase of Trial: Phase IV
Latest Information Update: 23 Sep 2013
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms REMOTE
- Sponsors Pfizer
- 23 Sep 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2012 Planned End Date changed from 1 Dec 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.